These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [A trial of the use of a new thrombolytic preparation--recombinant tissue-type plasminogen activator--in myocardial infarct patients]. Plotnikov AN; Staroverov II; Tagieva IA; Dorogun BN; Pomerantsev EV; Dobrovol'skiĭ AB; Ruda MIa Kardiologiia; 1993; 33(3):32-6. PubMed ID: 8377337 [TBL] [Abstract][Full Text] [Related]
28. [Experience with the thrombolytic therapy of myocardial infarct]. Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835 [No Abstract] [Full Text] [Related]
29. Retro-orbital hemorrhage after thrombolysis for acute myocardial infarction. Cunneen TS; Morlet N N Engl J Med; 2007 Oct; 357(14):1448-9. PubMed ID: 17914052 [No Abstract] [Full Text] [Related]
30. Thrombolysis using recombinant tissue-type plasminogen activator during cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest. Böttiger BW; Padosch SA Resuscitation; 2002 Mar; 52(3):308-9. PubMed ID: 11886741 [No Abstract] [Full Text] [Related]
31. [The clinical aspects of using thrombolytic therapy in myocardial infarct at the prehospital stage]. Staroverov II; Dundua DP; Plotnikov AN; Pomerantsev EV; Bliumental' AA; Puchkov AT; Ovasapian IuA; Serov VP; Ruda MIa Kardiologiia; 1993; 33(3):28-32. PubMed ID: 8377336 [TBL] [Abstract][Full Text] [Related]
32. Synergy between pharmacological and mechanical reperfusion in ST-segment elevation myocardial infarction patients: 2011 update. Cuisset T; Pankert M; Quilici J J Cardiovasc Med (Hagerstown); 2011 Dec; 12(12):860-7. PubMed ID: 22045096 [No Abstract] [Full Text] [Related]
33. Response to Letter Regarding Article, "Evolution From Fibrinolytic Therapy to a Fibrinolytic Strategy for Patients With ST-Segment-Elevation Myocardial Infarction". Bates ER Circulation; 2015 Jul; 132(1):e12. PubMed ID: 26149433 [No Abstract] [Full Text] [Related]
34. Spontaneous suprachoroidal hemorrhage secondary to thrombolysis for the treatment of myocardial infarction. Barsam A; Heatley CJ; Herbert L Clin Exp Ophthalmol; 2006 Mar; 34(2):177-9. PubMed ID: 16626438 [TBL] [Abstract][Full Text] [Related]
35. Early intravenous beta-blocker combined with thrombolytic therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI-2) Trial. Borzak S; Gheorghiade M Prog Cardiovasc Dis; 1993; 36(3):261-6. PubMed ID: 8234778 [No Abstract] [Full Text] [Related]
36. Haemarthrosis following thrombolytic therapy for acute myocardial infarction. Finlayson J; Dunsmuir RA Injury; 1997 Mar; 28(2):146-7. PubMed ID: 9205584 [No Abstract] [Full Text] [Related]
37. Letter by Weiss and Gotsman Regarding Article, "Evolution From Fibrinolytic Therapy to a Fibrinolytic Strategy for Patients With ST-Segment-Elevation Myocardial Infarction". Teddy Weiss A; Gotsman M Circulation; 2015 Jul; 132(1):e11. PubMed ID: 26149432 [No Abstract] [Full Text] [Related]
38. A case of intraocular haemorrhage secondary to thrombolytic therapy. Berry C; Weir C; Hammer H Acta Ophthalmol Scand; 2002 Oct; 80(5):561-2. PubMed ID: 12390175 [No Abstract] [Full Text] [Related]
39. Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group. Circulation; 2000 Jun; 101(24):2788-94. PubMed ID: 10859283 [TBL] [Abstract][Full Text] [Related]
40. GUSTO V: combination drug treatment of acute myocardial infarction. Global Use of Strategies to Open Occluded Coronary Arteries. Askari AT; Lincoff AM Cleve Clin J Med; 2002 Jul; 69(7):554-60. PubMed ID: 12109639 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]